The relation between M.M. and A.M.L., which involve distinct cell lines, remains puzzling. Long-term chemotherapy may have only a triggering role in patients with M.M. and some kind of pre-leukaemia state.
Introduction
The improvement in rate of remission and survival in acute ("childhood") lymphoblastic leukaemia (A.L.L.) (Spiers, 1972 is the major factor that has led to a more optimistic approach to A.L.L., which is still considered to be a homogeneous disease. Certain "bad-risk" cases are now recognized, however. For example, patients who have high blast cell counts, organomegaly, or marked thrombocytopenia at presentation fare relatively badly and also have a higher risk of developing meningeal leukaemia (Pavlovsky et al., 1973) . It has been suggested that patients with large blast cells (macroblasts) may obtain little benefit from immunotherapy (Mathe et al., 1971) , but morphological features are highly subjective and agreement between different centres is poor. A classification based on more objective criteria would be extremely valuable if specific cellular features could be shown to correlate with prognosis. In recent years markers for lymphoid cell differentiation have been used in the study of lymphoproliferative disorders. Though most cells from patients with A.L.L. seem to lack the surface markers for B and T lymphocytes (Lay et al., 1971; Smith et al., 1973 a) evidence is now accumulating that a significant minority may in fact be of T-cell type (Seligmann et al., 1973; Borella and Senn, 1973; Kersey et al., 1973; McCaffrey et al., 1973) . Furthermore, it has been suggested that the T-cell form of the disease is more aggressive (Borella and Sen, 1973) . We studied two further cases of T-lymphoblastic leukaemia in which its aggressive clinical course, in contrast to the usual type ofA.L.L., was clearly shown.
We report here the results of these studies because we believe that the immunological tests described should be applied to all new cases of A.L.L. The recognition of the T-lymphocyte origin of a proportion of cases of A.L.L. seems to have important therapeutic implications, but its true incidence cannot be assessed until a much larger series of patients has been studied. (Spiers, 1972 Pepys and Butterworth, 1974) . For T-cell markers the methods used were spontaneous sheep red cell rosette formation (Wybran et al., 1973) and transformation with phytohaemagglutinin (PHA) in a three-day suspension culture.
Cytochemical Stains.-The periodic-acid Schiff (P.A.S.), myeloperoxidase, Sudan black B, and acid phosphatase (Goldberg and Barka, 1962) reactions were studied on freshly made peripheral blood films after adequate fixation.
Scanning Electronmicroscopy.-Cells from the buffy coats were fixed in 1% glutaraldehyde and processed on silver membranes (Polliack et al., 1973) for critical point drying (Anderson, 1951) in carbon dioxide. They were then shadowed with gold palladium to a thickness of 50 nm and examined in the scanning electron microscope (Cambridge S4).
Results
All the investigations for B-cell markers (surface-bound immunoglobulins and Fc and C3 receptors) were negative. The sheep red cell rosette test was positive in both cases; 65% of the blast cells formed rosettes in case 1 and 60% in case 2. They were easily identified in cytocentrifuge preparations ( fig. 2 ). There was no transformation with PHA in the one patient studied (case 1).
The cytochemical reactions for myeloperoxidase and Sudan black B were negative in the blast cells of both cases. The P.A.S. reaction showed fine granules in 30% of the blasts of case 1, and in less than 5% of case 2. In the slides made at the time of presentation in case 2, however, 30% of the leukaemic cells showed large single blocks of P.A.S. positive material as is often seen in A.L.L., and a few cells showed several coarse blocks. The acid phosphatase reaction was moderately to strongly positive in more than 90% of the cells in both cases.
The appearance with the scanning electron microscope ( fig. 3) (x 4,500.) was the presence of surface blebs (see fig. 3 ). Two to 10 such blebs could be found in some cells, but they were not seen in cells with a smooth surface without digitations.
Discussion
In early studies on blast cells from patients with A.L.L. immunological markers for the identification of B lymphocytes only were used and these gave consistently negative results (Wilson and Nossal, 1971; Frpland et al., 1972; Shevach et al., 1972; Gutterman et al., 1973) . Thus, unlike, chronic lymphocytic leukaemia (C.L.L.) A.L.L. seemed not to be a B-cell malignancy.
More recently both B and T markers have been used, and a clearer picture of the findings in A.L.L. has emerged (Selig-645 mann et al., 1973; Borella and Sen, 1973; Kersey et al., 1973 It should be noted that thymic involvement was not present in most of these positive cases nor was it present in our two cases, which suggests that they do not represent the leukaemic phase of the so-called "Steinberg sarcoma" (Smith et al., 1973 a) .
The clinical implications of these earlier findings were not immediately obvious. Only Borella and Sen (1973) suggested a more aggressive or extensive disease in their patient with T-lymphoblastic leukaemia. Our two cases exemplified dramatically the aggressive nature of this variant of A.L.L. Both presented with extremely high blast cell counts (1000 x 103 and 170 x 103/1[), and their subsequent course, with early manifestations of meningeal leukaemia and some refractoriness to the intensive combination chemotherapy currently used in A.L.L., confirmed that they corresponded to a "bad-risk" group (Pavlovsky et al., 1973) . Interestingly three out of the five T-lymphoblastic patients reported by Kersey et al. (1973) had high leucocyte counts, while this was so in only one out of four of their non-T cases. It seems therefore from the 60 cases studied with B-and T-cell markers that T-lymphoblastic leukaemia may represent 20% or more of all cases of A.L.L., and it is associated with clinical and haematological features reflecting a more aggressive course. It has in the past been assumed that the "bad risk" in the "high leucocyte" group of patients was due to the relatively advanced stage at which the disease was diagnosed, but these patients may, in fact, have this distinct variant of A.L.L. Further studies in larger numbers of cases are essential to confirm these findings.
Two characteristics of the cells in our cases deserve further comment: their cytochemical profile and their surface structure. The P.A.S. reaction at the time of our study was positive in the form of small granules in only a few cells, while the acid phosphatase reaction was positive in most. These findings, unlike those commonly seen in other A.L.L. cases, were also observed in one case of T-prolymphocytic leukaemia, while the complete reverse, P.A.S. positivity in most of the leukaemic cells and a weak or negative acid phosphatase reaction, was observed in nine cases of leukaemia of B-cell type (B-prolymphocytic and C.L.L.; Catovsky et al., 1974) . These findings, which were not related to the degree of cellular differentiation, suggest basic metabolic differences between B and T lymphocytes which may be helpful in identifying these cells when classifying lymphoproliferative disorders.
Changes (Polliack et al., 1973; Lin et al., 1973) when the critical point drying technique is used (Anderson, 1951 (Lin et al., 1973) . Further studies on the surface structure of blast cells in A.L.L. may help to determine whether the appearance of microvilli correlates with T-cell differentiation.
It is clearly important to examine the blast cells from A.L.L. patients by the methods described to determine the proportion of T-cell cases. The use of specific anti-T sera may be necessary to identify some cases that would be missed by using only the sheep red cell rosette test (Kersey et al., 1973; Smith et al., 1973 b) . Other possible methods for establishing the T-cell nature of the cells include the establishment of permanent cell lines (Minowada et al., 1972) and the demonstration of a thymusspecific enzyme (McCaffrey et al., 1973) .
Finally, the extension of these studies may give further information on the possible viral aetiology of A.L.L. In intact mice virus-induced leukaemias have been shown to be of T-cell type while those induced by chemical carcinogens are of B-cell type (Haran-Ghera and Peled, 1973) . It is thus of great interest to establish whether the blast cells will prove to be of T-cell origin in all patients with A.L.L. or only in the minority as now seems to be the case. In the meantime the features noted in Tlymphoblastic leukaemia deserve further attention for they suggest that both clinically and haematologically it is a distinct variant of A.L.L.
